B Acute Lymphoblastic Leukemia

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Autologous Anti-CD19 CAR-expressing T Lymphocytes
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jan 30, 2023

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +5 more
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Oct 28, 2022

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +219 more
Sep 15, 2022

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Asparaginase Erwinia chrysanthemi
  • +15 more
  • Birmingham, Alabama
  • +219 more
Aug 24, 2022

B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

Recruiting
  • B-Cell Lymphoma
  • +8 more
  • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
  • Pittsburgh, Pennsylvania
    AHN Cancer Institute - West Penn Hospital
Aug 10, 2022

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • (no location specified)
Aug 2, 2022

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia, in Relapse
  • Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
  • Nivolumab starting at day -1
  • (no location specified)
Apr 4, 2022

B Acute Lymphoblastic Leukemia Trial in London (PBLTT52CAR19)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • London, United Kingdom
    Great Ormond Street Hospital
Dec 15, 2021

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

Active, not recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Birmingham, Alabama
  • +173 more
Nov 16, 2021

Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Minimal residual disease (MRD) monitoring
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 25, 2021

Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia

Terminated
  • Acute Lymphoblastic Leukemia in Remission
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 18, 2021

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • Blinatumomab
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2021

B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic

Completed
  • B Acute Lymphoblastic Leukemia
  • +3 more
  • AUTO3 (CD19/22 CAR T cells
  • London, United Kingdom
  • +2 more
Jan 11, 2021

B Acute Lymphoblastic Leukemia, Minimal Residual Disease, Recurrent Acute Lymphoblastic Leukemia Trial in Seattle (Laboratory

Terminated
  • B Acute Lymphoblastic Leukemia
  • +3 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2020

B Acute Lymphoblastic Leukemia, Leukemia Relapse Trial in France (Collection of blood samples)

Unknown status
  • B Acute Lymphoblastic Leukemia
  • Leukemia Relapse
  • Collection of blood samples
  • Amiens, France
  • +17 more
Feb 4, 2020

B Acute Lymphoblastic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Suzhou (CD19-CART)

Unknown status
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Suzhou, Jiangsu, China
    Hematology Department of the Second Affiliated Hospital of Suzho
Dec 1, 2019

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Seattle (drug,

Withdrawn
  • B Acute Lymphoblastic Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

B Acute Lymphoblastic Leukemia Trial in Kunming (prophylactic 4SCAR19 cells)

Unknown status
  • B Acute Lymphoblastic Leukemia
  • prophylactic 4SCAR19 cells
  • Kunming, Yunnan, China
    First people's hospital of Yunnan province
Nov 17, 2016